Shaigan Pharmaceuticals products and prices in Pakistan
Manufacturer Holds a DRAP Drug Manufacturing Licence (DML) for its products. Source: DRAP.
Follow price changes 🔒 Company report (Pharma Pro)Private pharmaceutical manufacturer · Rawalpindi · Pakistan
Rawalpindi-based pharmaceutical manufacturer focused on branded generic medicines, quality systems and international market expansion.
Shaigan Pharmaceuticals products in Pakistan
Shaigan Pharmaceuticals (Pvt) Ltd has 207 medicine presentations registered in Pakistan under 97 brands, covering 79 generic medicines. Most of its products are in Anti-infectives, Reproductive & genitourinary and Hematology & thrombosis. Its brands with the most registered strengths and packs are Celtis-1000 (Ceftriaxone), Celtis-250 (Ceftriaxone), Celtis-500 (Ceftriaxone) and Skab (Permethrin). 207 products have an official DRAP price on MedInfoBase. See all 97 brands A to Z
What is sourced, and how recent is it?
Regulatory-source portfolio data and company-supplied/corporate profile fields are tracked separately. Company claim/verification status is separate from source quality. An unclaimed company can still have a fully official-source-observed portfolio.
Company profile
- Legal / official name
- Shaigan Pharmaceuticals (Pvt.) Ltd.
- Company type
- Private pharmaceutical manufacturer
- Address
- 14-km, Adyala Road, Post Office Dahgal, Rawalpindi, Pakistan
- Website
- shaigan.com ↗
- Phone
- +92 51 5133060-8
- info@shaigan.com
- Official contact
- Contact page ↗
- Corporate source details checked
- 16 Aug 2026
- Corporate profile completeness
- 100%
Company location
A sourced company location is recorded. Use the map link below for directions.
Portfolio at a glance
RegistrationA unique regulatory registration number. One registration may have more than one strength/form/pack presentation.
PresentationA distinct medicine presentation, such as a particular strength, dosage form and pack.
IndexedA canonical MedInfoBase presentation that passed MedInfoBase identity and publication controls.
Source observedAn additional presentation observed in an official DRAP source but not counted as an indexed MedInfoBase presentation.
Registry onlyAn exact registry-verified registration not otherwise represented by an indexed or source-observed presentation.
Registry verifiedAn exact registration match found in an official DRAP registry source. This is evidence status, not a commercial ranking.
How complete is this profile?
Downloadable company intelligence charts
Copy or download any chart as a presentation-ready PNG. Every exported chart keeps MedInfoBase attribution and the source company-profile URL.
Therapeutic Portfolio Mix
Shows where the company portfolio is concentrated across broad therapeutic areas.
Portfolio distribution, not sales or market-share data.
Dosage Form Portfolio
Shows how the company portfolio is distributed across tablets, capsules, injections, liquids and other forms.
Counts are product presentations, not production or sales volumes.
Equivalent Price Position
Shows whether safely comparable products are below, near or above the peer median unit price.
This is price-position intelligence, not sales, demand or market-share data.
Closest Portfolio Competitors
Highlights other manufacturers with the greatest generic overlap with this company portfolio.
Competitor ranking is based on shared generics in MedInfoBase, not commercial sales performance.
Therapeutic areas
High-level clinical areas represented by this company’s current MedInfoBase portfolio.
Drug classes
More specific classes derived from the canonical generic and preserved curated classifications.
Dosage forms
How MedInfoBase classifies the portfolio
MedInfoBase uses a two-level taxonomy. Therapeutic area is a broad portfolio category, while drug class is the more specific pharmacological or clinical class. Existing curated classifications are preserved. Blank records are assigned conservatively from the canonical generic name and, when available, ATC information. Multi-use medicines may be placed in a cross-therapeutic category rather than forced into a single indication.
Deepest brand families
Unit-price positioning vs equivalent products
See where Shaigan Pharmaceuticals (Pvt) Ltd is priced against the market
183 of its products have like-for-like competitors. Pharma Pro shows how many are priced below, near or above the market median, the company's overall price position, and product-by-product examples.
How MedInfoBase calculates price position
Only current prices with safely interpretable pack quantities are used. A product is compared only with the same generic, same stated strength, same dosage form and a compatible unit basis such as tablet, capsule, mL or gram. These are database-derived price comparisons, not sales or market-share estimates.
Portfolio overlap
Companies sharing the largest number of generics with this portfolio. This measures product overlap, not commercial performance.
🔒 3 more overlapping companies, with shared-generic detail, in Pharma Pro. Unlock
Observed database signals
These dates describe records observed by MedInfoBase. They should not be interpreted as product launch dates or sales activity.
Medicine portfolio
This unified portfolio keeps three evidence lanes distinct: indexed MedInfoBase presentations, additional source-observed presentations, and registry-only registrations that are not otherwise represented. A registration number is not the same thing as a presentation, and source-observed rows are not counted as indexed. Source-only rows with a strength/form/pack contradiction remain visible as evidence but the conflicting field is held for normalization.
| Brand | Generic | Strength | Form | Pack | Registration | Source-listed price | Unit price | Price position |
|---|---|---|---|---|---|---|---|---|
| No matching products. | ||||||||
All 97 Shaigan Pharmaceuticals brands in Pakistan
- Acetosol Paracetamol · 120 mg/5 mL syrup, 500 mg tablet
- Amlopin Amlodipine · 5 mg tablet
- Anacor Betamethasone + Salicylic acid · 0.5 mg + 30 mg ointment
- Andogen Testosterone enanthate · 250 mg/mL injection
- Antimin Loratadine · 10 mg tablet, 5 mg/5 mL syrup
- Azicin Azithromycin · 250 mg capsule
- Azitrax Azithromycin · 200 mg/5 mL suspension, 250 mg capsule, 250 mg tablet
- Bexus Levofloxacin · 250 mg tablet, 500 mg tablet, 750 mg tablet
- Bisoprol Bisoprolol fumarate · 10 mg tablet, 2.5 mg tablet, 5 mg tablet
- Brotin Bromocriptine · 2.5 mg tablet
- Caber Cabergoline · 0.5 mg tablet
- Cecodin Paracetamol + Codeine · 500 mg + 15 mg tablet
- Ceftiz-1000 Ceftazidime · 1000 mg injection
- Ceftiz-250 Ceftazidime · 250 mg injection
- Ceftiz-500 Ceftazidime · 500 mg injection
- Celtis Ceftriaxone · 1000 mg injection, 250 mg injection, 500 mg injection
- Celtis-1000 Ceftriaxone · 1000 mg injection
- Celtis-250 Ceftriaxone · 250 mg injection
- Celtis-500 Ceftriaxone · 500 mg injection
- Cliver Cefotaxime · 1000 mg injection, 250 mg injection, 500 mg injection
- Clovir Aciclovir · 200 mg tablet, 200 mg/5 mL suspension, 5 % cream
- Clozox Clotrimazole · 10 mg cream, 100 mg tablet, 2% cream
- Contrex Hydroxyprogesterone caproate · 5 mg injection
- Cystexin Acetylcysteine · 200 mg sachet
- DCad-3 Cholecalciferol · 5000 IU capsule
- Declawin Daclatasvir · 60 mg tablet
- Derivax Calcipotriol · 50 µg cream
- Dibmet XR Metformin · 500 mg tablet
- Ditone E2 Viginal Dinoprostone · 3 mg tablet, 3 mg pessary
- Ditone F2 Dinoprostone · 5 mg/1 mL injection
- Doxycap Doxycycline · 100 mg capsule
- Ecad Elemental Calcium · 400 mg tablet
- Embex Rivaroxaban · 10 mg tablet, 15 mg tablet, 20 mg tablet
- Embex DS Rivaroxaban · 20 mg tablet
- Embex Forte Rivaroxaban · 15 mg tablet
- Emdagan 10 Empagliflozin · 10 mg tablet
- Emdagan 25 Empagliflozin · 25 mg tablet
- Emdagan Plus Empagliflozin + Metformin · 12.5 mg + 1000 mg tablet, 12.5 mg + 500 mg tablet, 12.5 mg + 850 mg tablet
- Enaril Enalapril · 10 mg tablet, 5 mg tablet
- Ergomin Methylergometrine Maleate · 0.2 mg/mL injection
- Fertab Clomifene citrate · 50 mg tablet
- Frenol Ibuprofen · 400 mg/100 mL infusion
- Glykin Amikacin · 100 mg injection, 250 mg injection, 500 mg injection
- Gravido Oseltamivir · 75 mg capsule
- Hygest Hydroxyprogesterone caproate · 250 mg/mL injection
- Hyvex Hydroxychloroquine · 200 mg tablet
- Iodino Potassium iodide · 130 mg tablet
- Iroton Iron, Iron polymaltose complex · 50 mg/5 mL syrup, 50 mg/mL drops
- Iroton Chewable Iron · 100 mg tablet
- Iroton-F Iron polymaltose complex + Folic acid · 100 mg elemental iron + 0.35 mg folic acid tablet
- Isopreg Dydrogesterone · 10 mg tablet
- Klolet Clopidogrel, Clopidogrel + Aspirin · 75 mg tablet, 75 mg + 150 mg tablet, 75 mg + 75 mg tablet
- L-ride Lidocaine · 1 % injection
- Laclose Lactulose · 3.35 g/5 mL syrup
- Latmo Eye Latanoprost · 50 mcg/mL drops
- Melofen Sulfadoxine + Pyrimethamine + Mefloquine · 500.0 mg + 25.0 mg + 274.0 mg tablet
- Melofin Sulfadoxine + Pyrimethamine · 500 mg + 25 mg tablet
- Mesan Niclosamide · 500 mg tablet
- Metni Metronidazole · 500 mg tablet
- Micasept Oral Miconazole · 20 mg/g gel
- Micasept Topical Miconazole · 20 mg/g cream
- Mionex Moxifloxacin · 400 mg tablet
- N-Glycrin SR Nitroglycerin · 2.6 mg tablet
- Nisale Sodium chloride · 0.9 % injection, 9 mg/mL injection
- Rapaza Ethinylestradiol · 0.02 mg tablet
- Remet-1.25 Ramipril · 1.25 mg tablet
- Remet-2.5 Ramipril · 2.5 mg tablet
- Remet-5 Ramipril · 5 mg tablet
- Riba Ribavirin · 400 mg capsule
- Riba-600 Ribavirin · 600 mg capsule
- Romycin Clarithromycin · 250 mg tablet, 500 mg tablet
- Ruvar 200 Lopinavir + Ritonavir · 200 mg + 50 mg tablet
- Ruwin Cefixime · 100 mg/5 mL suspension, 200 mg capsule, 200 mg/5 mL suspension
- Shai-C Ascorbic acid · 500 mg tablet
- Skab Permethrin · 5% w/w cream, 50 mg lotion, 50 mg/g cream
- Solone Prednisolone · 1 % suspension
- Sporay Itraconazole · 100 mg capsule
- Sterile WFI Water for Injection · 10 mL injection, 2 mL injection, 5 mL injection
- Sygate Conjugated estrogens · 0.3 mg tablet, 0.625 mg tablet, 1.25 mg tablet
- Temprin Artemether + Lumefantrine · 20 mg + 120 mg tablet, 240 mg + 240 mg tablet
- Temprin Plus Artemether + Lumefantrine · 80 mg + 480 mg tablet
- Ternifer Terbinafine · 1 % gel, 1 % cream
- Ticavir Entecavir · 0.5 mg tablet, 1 mg tablet
- Trozet Letrozole · 2.5 mg tablet
- Vebuvir Sofosbuvir · 400 mg tablet
- Vebuvir-L 400mg Sofosbuvir · 400 mg tablet
- Vebvel Sofosbuvir · 400 mg tablet
- Vyber Omeprazole · 20 mg capsule, 40 mg injection, 40 mg capsule
- Warfin Warfarin · 1 mg tablet, 2.5 mg tablet, 5 mg tablet
- Water Water for Injection · 1 mL injection
- Wetrex Furosemide · 50 mg tablet
- Wolide Linezolid · 100 mg/5 mL suspension, 400 mg tablet, 600 mg tablet
- Xepil Carbamazepine · 200 mg tablet
- Zedron Ondansetron · 2 mg/4 mL injection, 4 mg tablet, 4 mg/5 mL solution
- Zeflox Ciprofloxacin · 0.3% solution, 250 mg tablet, 500 mg tablet
- Zepar Albendazole · 200 mg tablet
- Zolric Zoledronic acid · 4 mg/100 mL infusion
Shaigan Pharmaceuticals: common questions
How many products does Shaigan Pharmaceuticals have in Pakistan?
Shaigan Pharmaceuticals (Pvt) Ltd has 207 registered medicine presentations in Pakistan, sold under 97 brands and covering 79 generic medicines.
What are the main brands of Shaigan Pharmaceuticals?
By number of registered strengths and packs, its largest brands are Celtis-1000 (Ceftriaxone), Celtis-250 (Ceftriaxone), Celtis-500 (Ceftriaxone), Skab (Permethrin) and Bexus (Levofloxacin). This is not a sales ranking.
Which therapy areas does Shaigan Pharmaceuticals cover?
The most products are in Anti-infectives (110), Reproductive & genitourinary (13), Hematology & thrombosis (13), Cardiovascular (11) and Endocrine & metabolic (11).
Where can I see Shaigan Pharmaceuticals medicine prices?
Open any brand in the list above for its official DRAP price, pack sizes, price history and other brands of the same medicine.
MedInfoBase company-intelligence methodology
This page is generated from MedInfoBase medicine, generic, company, price and official-source records. Unverified third-party discovery records are retained internally for coverage auditing and are not published as company registrations. Portfolio leaders are ranked by presentation depth, not sales. Price-position metrics are calculated from current official-source prices normalized to compatible units and compared only against like-for-like products with the same generic, stated strength and dosage form.
Not currently included: sales volume, revenue by brand, market share, prescription volume or best-selling rankings. MedInfoBase will display those only when supported by a defensible licensed, public or company-verified source.
Cite this record
Manufacturer recordRecords change over time. Please cite the access date so readers can locate the version you used.